Relevant bibliographies by topics / Immunosuppressants such as corticosteroids

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Immunosuppressants such as corticosteroids'

Author: Grafiati
Published: 5 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Immunosuppressants such as corticosteroids.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Immunosuppressants such as corticosteroids"

1

&NA;. "Corticosteroids/immunosuppressants." Reactions Weekly &NA;, no. 1171 (2007): 11–12. http://dx.doi.org/10.2165/00128415-200711710-00026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

&NA;. "Immunosuppressants/corticosteroids." Reactions Weekly &NA;, no. 431 (1992): 10. http://dx.doi.org/10.2165/00128415-199204310-00043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

&NA;. "Corticosteroids/immunosuppressants." Reactions Weekly &NA;, no. 1213 (2008): 15. http://dx.doi.org/10.2165/00128415-200812130-00042.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Corticosteroids/immunosuppressants." Reactions Weekly &NA;, no. 1217 (2008): 12–13. http://dx.doi.org/10.2165/00128415-200812170-00035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Corticosteroids/immunosuppressants/phenytoin." Reactions Weekly &NA;, no. 1174 (2007): 12–13. http://dx.doi.org/10.2165/00128415-200711740-00032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

&NA;. "Corticosteroids/immunosuppressants/infliximab." Reactions Weekly &NA;, no. 1208 (2008): 11. http://dx.doi.org/10.2165/00128415-200812080-00035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sechrist, Samantha J., Emily Tang, Benjamin F. Arnold, and Nisha R. Acharya. "Association between immunosuppressive medications and COVID-19 hospitalisation and death: a retrospective cohort study." BMJ Open 14, no. 12 (2024): e087467. https://doi.org/10.1136/bmjopen-2024-087467.

Full text
Abstract:
ImportanceImmunocompromised status is a risk factor for severe SARS-CoV-2 infection. Little is known about how systemic corticosteroid dose and concurrent use of immunosuppressants are associated with COVID-19 outcomes.ObjectiveTo assess the association between corticosteroid dose/duration and concurrent immunosuppressant use on COVID-19 hospitalisation and death in the era of COVID-19 vaccinations.DesignThis is a retrospective cohort study using a deidentified insurance claims database from 1 July 2020 to 30 June 30, 2022, with the risk period starting on 1 July 2021. Impact of corticosteroid
APA, Harvard, Vancouver, ISO, and other styles
8

Elmahdi, Rahma, Daniel Ward, Martin T. Ernst, et al. "Impact of immunosuppressive therapy on SARS-CoV-2 mRNA vaccine effectiveness in patients with immune-mediated inflammatory diseases: a Danish nationwide cohort study." BMJ Open 14, no. 2 (2024): e077408. http://dx.doi.org/10.1136/bmjopen-2023-077408.

Full text
Abstract:
ObjectivePatients receiving immunosuppressives have been excluded from trials for SARS-CoV-2 vaccine efficacy. Investigation of immunosuppressants’ impact on effectiveness of vaccines, particularly in patients with immune-mediated inflammatory diseases (IMID), is therefore required.DesignWe performed a nationwide cohort study to assess the risk of COVID-19 infection in vaccinated patients with IMID exposed to immunosuppressives compared with IMID unexposed to immunosuppressives. Exposure to immunosuppressives in the 120 days before receiving the second SARS-CoV-2 mRNA vaccination was assessed.
APA, Harvard, Vancouver, ISO, and other styles
9

Lam, Stefanie, Nilufar Partovi, Lillian SL Ting, and Mary HH Ensom. "Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction?" Annals of Pharmacotherapy 42, no. 7-8 (2008): 1037–47. http://dx.doi.org/10.1345/aph.1k62b.

Full text
Abstract:
Objective: To review the current clinical evidence on the effects of corticosteroid interactions with the immunosuppressive drugs cyclosporine, tacrolimus, mycophenolate, and sirotimus. Data Sources: Articles were retrieved through MEDLINE (1966–February 2008) using the terms corticosteroids, glucocorticoids, immunosuppressants, cyclosporine, tacrolimus, mycophenolate, sirolimus, drug Interactions, CYP3A4, P-glycoprotein, and UDP-glucuronosyltransferases. Bibliographies were manually searched for additional relevant articles. Study Selection and Data Extraction: All English-language studies de
APA, Harvard, Vancouver, ISO, and other styles
10

Tarhini, Ahmad A., Ni Kang, Sandra J. Lee, et al. "Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis." Journal for ImmunoTherapy of Cancer 9, no. 5 (2021): e002535. http://dx.doi.org/10.1136/jitc-2021-002535.

Full text
Abstract:
BackgroundThe impact of immune-related adverse events (irAEs) occurring from adjuvant use of immunotherapy and of their management on relapse-free survival (RFS) and overall survival (OS) outcomes is currently not well understood.Patients and methodsE1609 enrolled 1673 patients with resected high-risk melanoma and evaluated adjuvant ipilimumab 3 mg/kg (ipi3) and 10 mg/kg (ipi10) versus interferon-α. We investigated the association of irAEs and of use of immunosuppressants with RFS and OS for patients treated with ipilimumab (n=1034).ResultsOccurrence of grades 1–2 irAEs was associated with RFS
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Immunosuppressants such as corticosteroids"

1

Cattaneo, Dario. "Therapeutic drug monitoring of novel immunosuppressants." Thesis, Open University, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.424822.

Full text
Abstract:
Therapeutic drug monitoring is primarily undertaken for narrow therapeutic inde:drugs, such as immunosuppressants. These drugs have reduced the incidence of acute rejection and improved allograft survival. However, due to their narrow therapeutic index, small variations in blood levels may result in inadequate levels of immunosuppression or toxic drug concentrations. To overcome these problems individual dose regimen based-on phannacokinetic monitoring has been proposed in the past years. Indeed, several studies have previously documented a significant association between cyclosporine whole bl
APA, Harvard, Vancouver, ISO, and other styles
2

Choice, Edward G. "Liposomal immunosuppressants for the management of organ transplantation." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0032/NQ27119.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

陳錦源 and Kam-yuen Chan. "Design and synthesis of bucillamine analogs as immunosuppressants." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1997. http://hub.hku.hk/bib/B31213893.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chan, Kam-yuen. "Design and synthesis of bucillamine analogs as immunosuppressants /." Hong Kong : University of Hong Kong, 1997. http://sunzi.lib.hku.hk/hkuto/record.jsp?B18597919.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Smith, Kevin J. "Studies directed towards the synthesis of FK-506." Thesis, University of Southampton, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.239606.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

French, Martin Thomas. "Fluorescence immunoassay for cyclosporin A." Thesis, Loughborough University, 1991. https://dspace.lboro.ac.uk/2134/33279.

Full text
Abstract:
Monodansylcadavarine (MDC) was used to synthesise a fluorescent derivative of cyclosporin A and the product of the reaction was isolated by preparative thin layer chromatography (TLC) and purified by high performance liquid chromatography (HPLC). The fluorescent derivative was shown to bind with a polyclonal antibody to cyclosporin A by submitting the derivative for analysis by cyclosporin radioimmunoassay (RIA). However this derivative did not bind with a monoclonal antibody used in a RIA specific for the parent compound. To achieve this fluorescent derivatives were synthesised using cyclospo
APA, Harvard, Vancouver, ISO, and other styles
7

Norman, Joanne. "Synthetic studies on the C10-C17 fragment of rapamycin." Thesis, University of Cambridge, 1994. https://www.repository.cam.ac.uk/handle/1810/272766.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cairns, Jasmin. "Immunosuppressants and the renal transplant recipient : factors affecting adherence." Thesis, University of Manchester, 2012. https://www.research.manchester.ac.uk/portal/en/theses/immunosuppressants-and-the-renal-transplant-recipient-factors-affecting-adherence(c9be2ef8-6b8c-45ee-9061-057c93cbab49).html.

Full text
Abstract:
In renal transplantation, immunosuppressants are prescribed to patients to prevent graft loss. Although the extent of adherence required for such treatment to prevent graft loss has not been determined, it is thought to be high. Despite this, research suggests adherence rates for renal transplant recipients to be only between 50% and 95%. Considering the impact of graft loss on the renal patient, the national healthcare budget and on the limited resource of donor organs, it is important to identify and understand factors that contribute to nonadherence, and thereafter to address those that are
APA, Harvard, Vancouver, ISO, and other styles
9

Lundin, Anders. "Corticosteroids in Lumbar Disc Surgery." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6126.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Notari, Lorella. "Exogenous corticosteroids and dog behaviour." Thesis, University of Lincoln, 2016. http://eprints.lincoln.ac.uk/23697/.

Full text
Abstract:
Arousal and distress are considered important factors when dogs show problematic behaviours and the crucial role of hormones and neurotransmitters involved in stress responses is widely recognized. Corticosteroids are important players in stress responses and, along with other hormones and neurotransmitters, contribute to the onset of both physiological and behavioural changes that can be either normal and adaptive or excessive and maladaptive depending on several factors. A literature review revealed that exogenous corticosteroids have been reported to change behaviour in human beings and lab
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Immunosuppressants such as corticosteroids"

1

I, Maibach Howard, and Surber Christian 1955-, eds. Topical corticosteroids. Karger, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

J, Szefler S., and Leung Donald Y. M, eds. Corticosteroids in respiratory allergy. Saunders, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

F, Mantero, and Vecsei Pál, eds. Corticosteroids and peptide hormones in hypertension. Raven Press, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Barker, D. J. Topical corticosteroids & the treatment of eczema. University of Bradford.(School of Studies in Pharmacology), 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lahiri, Koushik, ed. A Treatise on Topical Corticosteroids in Dermatology. Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-4609-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cimaz, Rolando, ed. Systemic Corticosteroids for Inflammatory Disorders in Pediatrics. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-16056-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Stagg, Deborah Jane. The targeting of corticosteroids to inflamed tissues. Aston University. Department of Pharmacyand Biological Sciences, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rauz, Saaeha. Corticosteroids, 11[beta] - hydroxysteroid dehydrogenase isozymes and the human eye. University of Birmingham, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jacobs, Michael. The effect of lecithin on the topical delivery of corticosteroids. Brighton Polytechnic, Dept. of Pharmacy], 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Aghajafari, Fariba. Multiple vs. single courses of antenatal corticosteroids for preterm birth. National Library of Canada, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Immunosuppressants such as corticosteroids"

1

Bando, Masashi. "Pharmacotherapy of IPF (Corticosteroids, Immunosuppressants, Etc.)." In Idiopathic Pulmonary Fibrosis. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55582-7_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kruh, Jonathan, and C. Stephen Foster. "Corticosteroid-Sparing Agents: Conventional Systemic Immunosuppressants." In New Treatments in Noninfectious Uveitis. S. KARGER AG, 2012. http://dx.doi.org/10.1159/000336185.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Itoh, Masayuki. "Pharmacotherapy of Acute Exacerbation of IPF (Corticosteroids, Immunosuppressants, and Direct Hemoperfusion with Polymyxin)." In Idiopathic Pulmonary Fibrosis. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55582-7_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kürnsteiner, H., M. Zinner, and U. Kück. "Immunosuppressants." In Industrial Applications. Springer Berlin Heidelberg, 2002. http://dx.doi.org/10.1007/978-3-662-10378-4_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Patsalos, P. N. "Immunosuppressants." In Antiepileptic Drug Interactions. Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-2434-4_60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Patsalos, Philip N. "Immunosuppressants." In Antiepileptic Drug Interactions. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32909-3_64.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Stull, Carolyn, Michael Joseph Lavery, and Gil Yosipovitch. "Immunosuppressants." In Pruritus. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-33142-3_52.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Patsalos, Philip N. "Immunosuppressants." In Antiseizure Medication Interactions. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-82790-8_71.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, Ping. "Immunosuppressants Pharmacogenomics." In Pharmacogenomic Testing in Current Clinical Practice. Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-283-4_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Keller, Thomas H., Ren� Hersperger, and Giovanni Della Cioppa. "Macrocyclic Immunosuppressants." In New Drugs for Asthma, Allergy and COPD. KARGER, 2001. http://dx.doi.org/10.1159/000062179.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Immunosuppressants such as corticosteroids"

1

Chagas, Julia de Oliveira, Giovanna Alice de Oliveira Silva, Fernanda Mathias Rabelo Peixoto, Isadora Azevedo Cardeliquio Cantarelli, and Maycon Melo Lopes. "Disease associated with antiMOG antibody: a case report." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.353.

Full text
Abstract:
Introduction: Anti-MOG Antibody Associated Disease (MOGAD) is an autoimmune neurological condition with antibodies directed against the myelin glycoprotein of oligodendrocytes, with a monophasic or relapsing course. Symptoms include optic neuritis (ON), transverse myelitis, cerebral, brainstem, and cerebellar dysfunction. The diagnosis is based on the clinical picture and complementary exams, mainly the anti-MOG antibody. Treatment involves, in the acute phase, pulse with corticosteroids, plasmapheresis and, especially in children, immunoglobulin, and in the chronic phase (recurrent course), i
APA, Harvard, Vancouver, ISO, and other styles
2

Kwon, H. H., S. Y. Bang, S. Won, et al. "THU0356 Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.3438.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pereira, Clarice de Abreu, Amanda Souza Bandeira, Gabriel Luis Pozzan, Luis Guilherme Fernandes Costa Lima, and Adeni Ferreira dos Santos Junior. "Bacteriophages in the treatment of Inflammatory Bowel Disease." In III Seven International Medical and Nursing Congress. Seven Congress, 2024. http://dx.doi.org/10.56238/iiicongressmedicalnursing-030.

Full text
Abstract:
Introduction: Inflammatory bowel diseases are the result of an interaction between environmental, genetic and immunological factors, which result in a persistent inflammatory process in the intestines. The relationship between the intestinal microbiota and its influence and possible changes in IBD is not completely clear, however it is believed that the existence of a local inflammatory process generates changes, i.e. intestinal dysbiosis, often associated with the development of symptoms. The treatment of IBD depends on the signs and symptoms presented by the patient and may include aminosali
APA, Harvard, Vancouver, ISO, and other styles
4

Mei, Ting, and Youling Gong. "520 Initial strategy of corticosteroids-immunosuppressant treatment and the consequent clinical outcome among non-small cell lung cancer patients with severe checkpoint inhibitor pneumonitis." In SITC 38th Annual Meeting (SITC 2023) Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jitc-2023-sitc2023.0520.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zen, Margherita. "14 Can we withdraw immunosuppressants in remitted patients?" In 9th Annual Meeting of the Lupus Academy. Lupus Foundation of America, 2020. http://dx.doi.org/10.1136/lupus-2020-la.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Silva, Jacqueline, Daniel Jupiter, and Giulio Taglialatela. "Retrospective Analyses of Dementia Outcomes in Patients Prescribed Immunosuppressants." In ASPET 2023 Annual Meeting Abstracts. American Society for Pharmacology and Experimental Therapeutics, 2023. http://dx.doi.org/10.1124/jpet.122.289340.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

ROCHA, ANA MEL, GABRIELLA BENTO DE MORAIS, NATANAEL FERREIRA PAULA, ARTHUR GUILHERME DANTAS, and TAYNAH ALMEIDA MELO. "PREOPERATIVE CARE USING IMMUNOSUPPRESSANTS ASSOCIATED WITH CORTICOTHERAPY IN ARTERITIS." In 36º Congresso Brasileiro de Reumatologia. Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-540.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dementyeva, Elena, Valentina Aksenova, Alexey Kazakov, and Nadezhda Klevno. "Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa2285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mustafayeva, L., I. Durucan, AY Ayla, and S. Ugurlu. "PO.3.68 Systemic lupus erythematosus-related intestinal pseudo-obstruction treated with immunosuppressants." In 13th European Lupus Meeting, Stockholm (October 5–8, 2022). Lupus Foundation of America, 2022. http://dx.doi.org/10.1136/lupus-2022-elm2022.97.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Santos, Camila Cristina, Wagner Mendes Moura, Crisellen Delogo Sinete, et al. "IMMUNOSUPPRESSANTS-INDUCED HIDRADENITIS SUPPURATIVA IN PATIENTS WITH RHEUMATOID ARTHRITIS: THREE CASE REPORTS." In XLI Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2024. https://doi.org/10.47660/cbr.2024.1907.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Immunosuppressants such as corticosteroids"

1

Zhong, Xiaoling, and Rong Luo. Efficacy and Safety of Non-Corticosteroid Immunosuppressants in Juvenile Myasthenia Gravis: A systematic review and meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.3.0109.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Canellas, Joao Vitor, Fabio Ritto, and Paul Tiwana. Comparative efficacy and safety of different corticosteroids to reduce inflammatory complications after mandibular third molar surgery: a systematic review and network meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.9.0023.

Full text
Abstract:
Review question / Objective: This systematic review aims to compare the effects of different corticosteroids to reduce postoperative inflammatory complications (pain, edema, and trismus) after mandibular third molar surgery by applying a frequentist network meta-analysis approach. To this end, the proposed study will answer the following questions: 1) Among diverse corticosteroids currently available, what is the best preoperative option to control postoperative inflammatory complications? 2) What is the optimal dose and route of administration of corticosteroids prior to mandibular third mola
APA, Harvard, Vancouver, ISO, and other styles
3

Chai, Tianci, Zhihuang Qiu, Jian He, et al. Can high-dose corticosteroids in cardiopulmonary bypass bring more benefits？. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.6.0080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sobieraj, Diana M., William L. Baker, Erin R. Weeda, et al. Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma. Agency for Healthcare Research and Quality, 2017. http://dx.doi.org/10.23970/ahrqepccer194.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zhao, Binghao. Systemic Corticosteroids Administration in Coronavirus Disease 2019 Outcomes: an Umbrella Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.1.0116.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Yin, Ziqian, Youjia Qiu, Aojie Duan, et al. Different monoclonal antibodies and immunosuppressants administration in patients with Neuromyelitis Optica Spectrum Disorder: A Bayesian Network Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lewis, James, Meenakshi Bewtra, Frank Scott, et al. Patient Valued Comparative Effectiveness of Corticosteroids versus Anti-TNF Alpha Therapy for Inflammatory Bowel Disease. Patient-Centered Outcomes Research Institute (PCORI), 2018. http://dx.doi.org/10.25302/11.2018.ce.12114143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Li, Zhaolun, and David Denning. A systematic review and meta-analysis: The impact of corticosteroids onthe outcome of fungal disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.8.0110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Canellas, Joao Vitor, Fabio Ritto, and Paul Tiwana. Comparative efficacy and safety of pharmacological interventions to reduce inflammatory complications after mandibular third molar surgery: a systematic review and network meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.7.0069.

Full text
Abstract:
Review question / Objective: This systematic review aims to compare the effects of different drugs to reduce postoperative inflammatory complications (pain, edema, and trismus) after mandibular third molar surgery by applying a frequentist network meta-analysis approach. To this end, the proposed study will answer the following questions: 1) Among diverse drugs currently available, which postoperative pharmacological regimen is the most efficient to reduce pain after mandibular third molar surgery? 2) Is the pre-emptive analgesia effective in reducing pain immediately after the mandibular thir
APA, Harvard, Vancouver, ISO, and other styles
10

Lin, Dongxin, Dazhi Fan, Gengdong Chen, Caihong Luo, Xiaoling Guo, and Zhengping Liu. Association of antenatal corticosteroids with morbidity and mortality among multiple gestations: a protocol for meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.10.0105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Immunosuppressants such as corticosteroids' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography